Gabapentin is FDA-approved for epileptic seizures and postherpetic neuralgia, which is lasting pain after a shingles infection. Its off-label uses are climbing as physicians discover new applications, The New York Times reported Aug. 17.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
